* “Ginkgetin is synergized with DDP to increase cytotoxicity in NSCLC cells.”* “Ginkgetin disrupted redox hemostasis in DDP-treated cells, as demonstrated by the enhanced ROS formation and inactivation of the Nrf2/HO-1 axis.”* “Ginkgetin increased labile iron pool and lipid peroxidation and caused elevation of ROS formation, and apoptosis in DDP-treated NSCLC cells.” This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.